...

首页> 外文期刊>Journal for ImmunoTherapy of Cancer >A Phase I, open-label, dose escalation study of MGA271 in combination with ipilimumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck or non-small cell lung cancer

【24h】

A Phase I, open-label, dose escalation study of MGA271 in combination with ipilimumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck or non-small cell lung cancer

机译：MGA271联合ipilimumab在B7-H3表达黑素瘤，头颈部鳞状细胞癌或非小细胞肺癌患者中进行的I期开放标签剂量递增研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal for ImmunoTherapy of Cancer》 |2015年第s2期|共页
作者
Walter Urba; Bartosz Chmielowski; Deryk Loo; Jan Baughman; Francine Chen; Paul Moore; Ezio Bonvini; James Vasselli; Jon Wigginton; Naiyer Rizvi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer [J] . Kerry Lynn Reynolds, Philippe L. Bedard, Se-Hoon Lee, BMC Cancer . 2017,第1期

机译：抗HER3单克隆抗体LJM716在晚期食道或头颈部鳞状细胞癌和HER2过表达的乳腺癌或胃癌患者中的I期开放标签剂量递增研究
2. A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer [J] . Kerry Lynn Reynolds, Philippe L. Bedard, Se-Hoon Lee, BMC Cancer . 2017,第1期

机译：抗HER3单克隆抗体LJM716在晚期食道或头颈部鳞状细胞癌和HER2过表达的乳腺癌或胃癌患者中的I期开放标签剂量递增研究
3. Debio 1143 in combination with carboplatin and paclitaxel in patients with non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC) and platinum-refractory epithelial ovarian cancer (EOC). Preliminary results of a Phase I dose-escalation study [J] . Le Tourneau C., Ray-Coquard I., Isambert N., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2014,第Suppla6期

机译：非小细胞肺癌（NSCLC），三阴性乳腺癌（TNBC）和铂难治性上皮性卵巢癌（EOC）患者中的Debio 1143与卡铂和紫杉醇联合使用。一期剂量递增研究的初步结果
4. Adenylyl Cyclase-Associated Protein 1 in Metastasis of Squamous Cell Carcinoma of the Head and Neck and Non-Small Cell Lung Cancer [C] . G. V. Kakurina, E. S. Kolegova, O. V. Cheremisina, International Conference on Physics of Cancer . 2016

机译：腺苷酸环酶相关蛋白1在头部和颈部和非小细胞肺癌的鳞状细胞癌转移中
5. Enhancing the Therapeutic Effects of Low Doses of Ionizing Radiation in Non-Small Cell Lung Cancers Using a Combination of PARP Inhibitors and DNA Demethylating Agents. [D] . Biondi, Christopher Anthony. 2016

机译：使用PARP抑制剂和DNA去甲基化剂的组合增强非小细胞肺癌低剂量电离辐射的治疗效果。
6. A Phase I open-label dose escalation study of MGA271 in combination with ipilimumab in patients with B7-H3-expressing melanoma squamous cell cancer of the head and neck or non-small cell lung cancer [O] . Walter Urba, Bartosz Chmielowski, Deryk Loo, 2015

机译：MGA271联合ipilimumab在B7-H3表达黑素瘤头颈部鳞状细胞癌或非小细胞肺癌患者中进行的I期开放标签剂量递增研究
7. A Phase I, open-label, dose escalation study of MGA271 in combination with ipilimumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck or non-small cell lung cancer [O] . Walter Urba, Bartosz Chmielowski, Deryk Loo, 2015

机译：MGA271联合ipilimumab在B7-H3表达黑素瘤，头颈部鳞状细胞癌或非小细胞肺癌患者中进行的I期开放标签剂量递增研究

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号